Secukinumab safety and tolerability in subjects with moderate to severe plaque psoriasis: A pooled subgroup analysis of 10 clinical studies evaluating exacerbation of Crohn’s disease

2014 ◽  
Vol 70 (5) ◽  
pp. AB188 ◽  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Plaque Psoriasis ◽  
Subgroup Analysis ◽  
Clinical Studies ◽  
Severe Plaque Psoriasis

scholarly journals Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

2018 ◽  
Vol 35 (4) ◽  
pp. 563-576 ◽  
Author(s):  
Edouard J. Louis ◽  
Walter Reinisch ◽  
David A. Schwartz ◽  
Robert Löfberg ◽  
Anne M. Robinson ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Clinical Studies ◽  
Pooled Analysis ◽  
Extraintestinal Manifestations

Sa1734 - Impact of Prior Surgical History on Efficacy with Ustekinumab in Crohn's Disease: A Subgroup Analysis of the Phase 3 Uniti Studies

2018 ◽  
Vol 154 (6) ◽  
pp. S-373-S-374 ◽  
Author(s):  
Stephen B. Hanauer ◽  
Christopher Gasink ◽  
Timothy Hoops ◽  
Long-Long Gao ◽  
Benjamin Yeager ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Subgroup Analysis ◽  
Phase 3 ◽  
Surgical History

Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis

2016 ◽  
Vol 75 (1) ◽  
pp. 83-98.e4 ◽  
Author(s):  
Peter C.M. van de Kerkhof ◽  
Christopher E.M. Griffiths ◽  
Kristian Reich ◽  
Craig L. Leonardi ◽  
Andrew Blauvelt ◽  
...  
Keyword(s):  
Phase Ii ◽  
Plaque Psoriasis ◽  
Clinical Studies ◽  
Pooled Analysis ◽  
Severe Plaque Psoriasis ◽  
Phase Ii And Iii

scholarly journals Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1)

2017 ◽  
Vol 44 (11) ◽  
pp. 1285-1290 ◽  
Author(s):  
Shinichi Imafuku ◽  
Hitoe Torisu-Itakura ◽  
Atsushi Nishikawa ◽  
Fangyi Zhao ◽  
Gregory S. Cameron ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Severe Plaque Psoriasis
Sign in / Sign up

Export Citation Format

Share Document